Generated by AI
Harvard Bioscience Inc. is a life sciences tools and instruments company that develops, manufactures, and sells technologies, products, and services used in research, discovery, and preclinical testing. Harvard Bioscience’s offerings support a broad range of laboratory workflows, including cellular and molecular biology, electrophysiology, physiological measurement, data acquisition, and bioproduction. Its product portfolio serves academic institutions, pharmaceutical and biotechnology companies, contract research organizations, and government laboratories worldwide. The company’s current business is organized around specialized platforms for research instrumentation and preclinical systems, helping scientists generate and analyze data across drug discovery, therapy development, and laboratory experimentation. With operations and sales reach across major global markets, Harvard Bioscience holds a focused role in the life sciences tools sector as a supplier of precision instruments and related consumables for scientific and biomedical research.
Website84 October Hill Road
Holliston, MA, 01746
United States
The latest articles about HBIO.
Summary of Mar 17's posts. Generated by AI.
Summary of Mar 16's posts. Generated by AI.
Summary of Mar 16's posts. Generated by AI.
Investors talking about HBIO also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.